Adagene Pte. Ltd.
Patents held now
No granted US patent is recorded under this name. The published applications below are what the record holds.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 pending · 1 abandoned · 4 no status recorded
Showing 1 to 10 of 10, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 19/110,046 | Activatable ANTI-CTLA4 Antibodies for Treating Cancer | Sep 8, 2023 | Pending |
| 18/855,066 | Anti-CD28 Antibodies and Methods of Use Thereof | Apr 10, 2023 | Pending |
| 18/842,313 | Mar 6, 2023 | No status recorded | |
| 18/705,386 | ANTI-CD47 Antibodies and Methods of Use Thereof | Oct 27, 2022 | Pending |
| 18/553,043 | Methods for Treating Cancer Using ANTI-CTLA4 Antibodies | Mar 28, 2022 | Pending |
| 18/546,246 | Feb 11, 2022 | No status recorded | |
| 18/011,801 | Combination Therapy Comprising ANTI-CD137 Antibodies | Jun 23, 2021 | Abandoned |
| 17/924,540 | May 13, 2021 | No status recorded | |
| 17/759,282 | Heterodimeric Proteins with FC Mutations | Jan 22, 2021 | Pending |
| 17/612,878 | Jun 4, 2020 | No status recorded |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built